Navigation Links
Cephalon Announces Definitive Agreement to Acquire Gemin X
Date:3/21/2011

, Inc.

Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com

About Gemin X Pharmaceuticals, Inc.

Gemin X currently has several clinical development programs underway, including Phase 2 clinical trials for its lead product candidates obatoclax (GX15-070), an innovative pan Bcl-2 inhibitor, and teglarinad (GMX1777), a novel inhibitor of NAD+ synthesis. Gemin X also has a preclinical telomere capping program. Founded in 1998 as a spin-out of McGill University, Gemin X is a private company with drug development and executive headquarters in Malvern, Pennsylvania and drug discovery and research operations in Montréal, Canada. Investors in the company include leaders in life sciences investing such as Caxton Advantage Life Sciences Fund and Sanderling Ventures.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory ap
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkins Lymphoma
3. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
4. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
5. Cephalon Signs Option Agreement to Acquire Ception Therapeutics
6. Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
7. Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
8. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
10. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 5, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... treatment of chronic pain, today announced the appointment ... roles. The panel of experts will provide support ... to advance the company pipeline of novel investigational ... in a range of areas including opioid receptors, ...
(Date:3/5/2015)... 2015  Celsion Corporation (NASDAQ: CLSN ... a conference call to discuss year-end 2014 financial ... programs for ThermoDox®, its proprietary heat-activated liposomal encapsulation ... TheraPlas™ and TheraSilence™, in immunotherapy and RNA delivery ... 2015. To participate in the call, interested parties ...
(Date:3/5/2015)... WASHINGTON , March 5, 2015 ... applauds the Food and Drug Administration,s (FDA) approval ... (nivolumab). Opdivo and other immunotherapy treatments add another ... by harnessing the power of a patient,s own ... drug has been approved specifically for patients with ...
Breaking Medicine Technology:Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 2Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 3Relmada Therapeutics Names Leading Clinicians and Researchers in Pain Therapy Development to Advisory Roles 4Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
... Inc. (Nasdaq: ESRX ) announced 2010 third quarter net ... share.  Third quarter adjusted earnings per share, as detailed in Table ... 2009. Third Quarter 2010 Review (2010 ... Total adjusted claims of 186.9 million, up 48% ...
... partnerships to expand access to health care in the ... provided more than $34 million in grants and product ... maternal and child health, diabetes, HIV/AIDS and malnutrition. ... Abbott products were in use immediately ...
Cached Medicine Technology:Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 2Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 3Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 4Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 5Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 6Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 7Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 8Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 9Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 10Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 11Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 12Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 13Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 14Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 15Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 16Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti 2
(Date:3/5/2015)... Altec Products, Inc., a leader in enterprise ... in the Houston, TX and Charlotte, NC conferences of ... unite Sage enterprise resource planning (ERP) software users with ... real-world business challenges. , The Houston, TX event ... Area on March 10th. The Charlotte, NC conference will ...
(Date:3/5/2015)... 05, 2015 March 5, 2015 – ... next week (March 8-14, 2015), children’s hospitals around the ... in making hospital stays as safe as possible for ... hospitals—Children’s Hospitals’ Solutions for Patient Safety (SPS) and the ... families to follow when visiting the hospital with their ...
(Date:3/5/2015)... GA (PRWEB) March 05, 2015 ... and relationship-marketing firm, honored finalists and winners Thursday ... Executive Forum and Awards Gala at the Westin ... chief security officer for EarthLink, was selected as ... winner for the ISE® Southeast Region. Pete is ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
(Date:3/5/2015)... Grants Pass, OR (PRWEB) March 05, 2015 ... dehydrated and increasing the amount of water one drinks ... individuals. Those were the conclusions of fresh water advocate ... recent interview on the Sharon Kleyne Hour™ Powers of ... of Podiatric Medicine (DPM) specializing in podiatry, orthotics and ...
Breaking Medicine News(10 mins):Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 2Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 3Health News:Children’s Hospitals Offer Safety Tips for Patient Families During National Patient Safety Awareness Week 4Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 2Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 3Health News:Pete Chronis of EarthLink and Jabil Claim Top Awards at ISE® Southeast 4Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 2Health News:Obesity is dehydrating and drinking water promotes weight loss say fresh water advocates 3
... http://www.westaim.com , CALGARY, Nov. 7 /PRNewswire-FirstCall/ - The ... on Tuesday, November 13, 2007 regarding the,Company,s 2007 third ... wire services, a news release,and financial statements will be ... call live on the Internet, please go to ...
... 7 Rapid Pathogen Screening Inc.,(RPS) -- a ... -- announced today that the American Medical Association ... that will cover the,RPS Adeno Detector(TM), effective January ... "Infectious agent antigen detection by immunoassay with direct ...
... The following is a,written statement by Kevin ... Force on Intellectual Property, at the Senate Judiciary,Committee ... Chairman Leahy, Ranking Member Specter, and Members ... discuss the Department of Justice,s,efforts to protect intellectual ...
... longer than previously assumed , WEDNESDAY, Nov. 7 (HealthDay ... according to a study that found the duration of ... That means many people may be getting booster shots ... say. , Based on the findings, it may be ...
... their risk for neurodevelopmental trouble, researchers say, , , WEDNESDAY, ... couldn,t live without their morning coffee, but caffeine may ... premature infants. , New research finds that high doses ... -- an average of 27 weeks gestation -- reduced ...
... NEWS, Va., Nov. 7 This past weekend ... Compact Gamma,Cameras" were presented at the Nuclear Science ... The goal of the laboratory study was to ... system in a configuration in which,the two imaging ...
Cached Medicine News:Health News:American Medical Association Clears Path for Adenoviral Conjunctivitis - 'Pink Eye' - Detector 2Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 2Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 3Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 4Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 5Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 6Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 7Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 8Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 9Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 10Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 11Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 12Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 13Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 14Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 15Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 16Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 17Health News:Written Statement of Kevin J. O'Connor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement 18Health News:Many Vaccine Booster Shots Unnecessary: Study 2Health News:Caffeine Therapy Boosts Preemies' Outcomes 2Health News:Caffeine Therapy Boosts Preemies' Outcomes 3Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 3
... System has been designed so the surgeon ... soft tissue away from the operative surface. ... procedure without stay-sutures or assistance. This controlled ... freedom to do other tasks, which will ...
... a revolutionary new addition to the Hall® ... PowerPro Battery System is the first and ... on the market. It is a full-function ... the requirements of large bone, small bone, ...
... Plus is a truly flexible system offering ... range of applications, inlcuding orthopedics, abdominal surgery, ... and more. , ,By offering ... sizes, evolutive memory capacities and a wide ...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
Medicine Products: